Rhenman & Partners Asset Management’s IGM Biosciences IGMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-126,064
| Closed | -$770K | – | 97 |
|
|
2024
Q4 | $770K | Sell |
126,064
-59,395
| -32% | -$363K | 0.08% | 90 |
|
|
2024
Q3 | $3.07M | Sell |
185,459
-9,541
| -5% | -$158K | 0.25% | 82 |
|
|
2024
Q2 | $1.34M | Hold |
195,000
| – | – | 0.13% | 84 |
|
|
2024
Q1 | $1.88M | Sell |
195,000
-5,000
| -3% | -$48.3K | 0.18% | 77 |
|
|
2023
Q4 | $1.66M | Hold |
200,000
| – | – | 0.17% | 76 |
|
|
2023
Q3 | $1.67M | Hold |
200,000
| – | – | 0.18% | 74 |
|
|
2023
Q2 | $1.85M | Buy |
200,000
+105,000
| +111% | +$969K | 0.19% | 76 |
|
|
2023
Q1 | $1.62M | Buy |
95,000
+45,000
| +90% | +$766K | 0.18% | 78 |
|
|
2022
Q4 | $851K | Buy |
+50,000
| New | +$851K | 0.09% | 92 |
|